Cancer

The latest cancer news from UNC Health Care and the UNC School of Medicine.

New mouse model to aid testing of Zika vaccine, therapeutics

New mouse model to aid testing of Zika vaccine, therapeutics

A research team including Helen Lazear, PhD, assistant professor of microbiology and immunology, has established a mouse model for testing of vaccines and therapeutics to battle Zika virus.

New mouse model to aid testing of Zika vaccine, therapeutics - Read More…

Microneedle patch delivers localized cancer immunotherapy to melanoma

Microneedle patch delivers localized cancer immunotherapy to melanoma

UNC / NC State researchers devise a new nanotechnology to enhance the body’s own immune response to kill skin cancer tumors.

Microneedle patch delivers localized cancer immunotherapy to melanoma - Read More…

Study uncovers genetic differences for kidney cancer that may contribute to survival disparity in African-Americans

Study uncovers genetic differences for kidney cancer that may contribute to survival disparity in African-Americans

A UNC Lineberger-led study has identified genetic differences in tumors of African-Americans with the most common type of kidney cancer compared with whites. The researchers say the findings could help explain lower survival rates for African-Americans with clear cell renal cell carcinoma.

Study uncovers genetic differences for kidney cancer that may contribute to survival disparity in African-Americans - Read More…

UNC Hospitals’ care earns Blue Distinction® Center+ Designation for Quality and Cost-Efficiency for Five Service Lines

Blue Cross and Blue Shield of North Carolina ranked UNC Hospitals’ bariatric surgery, cardiac care, knee & hip replacement, spine surgery, maternity and complex & rare cancer service lines highly as part of the Blue Distinction Specialty Care program

UNC Hospitals’ care earns Blue Distinction® Center+ Designation for Quality and Cost-Efficiency for Five Service Lines - Read More…

Using new drug screening tool, UNC researchers identify potential treatments for Ewing sarcoma

Using new drug screening tool, UNC researchers identify potential treatments for Ewing sarcoma

In a first-of-its-kind-study, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse abnormal DNA unwinding in Ewing sarcoma, a bone and soft tissue cancer that’s most common in teens and young adults.

Using new drug screening tool, UNC researchers identify potential treatments for Ewing sarcoma - Read More…

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship

The joint UNC/NC State researcher also earned a grant from JDRF and Sanofi to further develop glucose responsive insulin therapies for diabetes.

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship - Read More…

UNC experts talk ‘Cancer Moonshot’ with Vice President Biden

As part of the “Cancer Moonshot” federal initiative to spur breakthroughs in cancer research, Biden hosted a roundtable discussion on Feb. 10 at the Duke University School of Medicine that featured cancer experts and leaders from UNC. Among the experts chosen for the panel were Stephanie Wheeler, PhD, UNC Lineberger member and assistant professor of health policy and management at the UNC Gillings School of Global Public Health, and Niklaus Steiner, UNC professor and co-founder of the Chapel Hill-based Be Loud! Sophie Foundation, which supports adolescents and young adults with cancer.

UNC experts talk ‘Cancer Moonshot’ with Vice President Biden - Read More…

Low-risk prostate cancer best managed with active surveillance, according to new recommendations

Low-risk prostate cancer best managed with active surveillance, according to new recommendations

A UNC Lineberger researcher was first-author of a report published in the Journal of Clinical Oncology that details guidelines for the active surveillance of men with low-risk prostate cancer. The guidelines, originally authored by Cancer Care Ontario, were reviewed and endorsed by the American Society of Clinical Oncology with some revisions.

Low-risk prostate cancer best managed with active surveillance, according to new recommendations - Read More…

Study finds gaps in patient knowledge of breast reconstruction surgery and complications

Study finds gaps in patient knowledge of breast reconstruction surgery and complications

In a study published in the journal Annals of Surgery, researchers report that breast cancer patients surveyed about their knowledge of breast reconstruction were only moderately informed about the procedure, and their knowledge of complications was low.

Study finds gaps in patient knowledge of breast reconstruction surgery and complications - Read More…

UNC Lineberger researchers identify DNA repair enzyme as a potential brain cancer drug target

UNC Lineberger researchers identify DNA repair enzyme as a potential brain cancer drug target

In the journal Cell Reports, UNC Lineberger researchers report that when they removed Dicer from preclinical models of medulloblastoma, a common type of brain cancer in children, they found high levels of DNA damage in the cancer cells, leading to the cells’ death.

UNC Lineberger researchers identify DNA repair enzyme as a potential brain cancer drug target - Read More…

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells

The new cancer drug delivery system improved efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.

Liquid Metal ‘Nano-Terminators’ Target Cancer Cells - Read More…

False-positive mammograms may indicate increased risk of breast cancer

False-positive mammograms may indicate increased risk of breast cancer

Findings suggest that radiologists studying mammograms observed suspicious markers that could have been indications of future cancer development.

False-positive mammograms may indicate increased risk of breast cancer - Read More…

UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars

UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars

The award, made possible through a donation from Lenovo chairman and CEO Yuanqing Yang, recognizes the research achievements of young tenured faculty.

UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars - Read More…

UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk

UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk

A UNC Lineberger-led study published in the New England Journal of Medicine found that vitamin D and calcium supplements do not reduce the risk of colorectal adenomas, which are benign tumors that can evolve into colorectal cancer.

UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk - Read More…

And Then There Were Two . . .

And Then There Were Two . . .

From aspiring soccer star to world-renowned biochemist, Aziz Sancar, MD, PhD, joined Carolina’s other Nobel Laureate, Oliver Smithies, PhD, during a celebration of science at the UNC School of Medicine.

And Then There Were Two . . . - Read More…

UNC Cancer: Lifting Patients Up

UNC Cancer: Lifting Patients Up

In the recent U.S. News and World Report rankings of America’s Best Hospitals, UNC Hospitals was nationally ranked in five of the 16 specialties. In this series, we profile these specialties to learn more about what makes them so outstanding.

UNC Cancer: Lifting Patients Up - Read More…

Scientists disguise drugs as platelets to target cancer cells

Scientists disguise drugs as platelets to target cancer cells

The new drug-creation method could allow cancer drugs to last longer in the body to attack tumors, as well as cancer cells floating in the blood stream.

Scientists disguise drugs as platelets to target cancer cells - Read More…

Share This: